Introduction
OC N-(CH2)3CONH2 y-Piperidinobutyramide (Wy 20051, DF480) a close derivative of y-aminobutyric acid (GABA) was originally synthesized for comparative studies with the parent compound on the central nervous system. During examination of the pharmacology of Wy 20051 in the anaesthetized rat, it was observed that intravenous administration evoked transient pressor responses. The experiments described in this paper were designed to investigate the mode and site of action of this unusual pressor activity.
Methods
Intact animal studies Female Charles River rats weighing 200-250 g were anaesthetized with pentobarbitone sodium (2.3 x 10-4 mollkg i.p.). Each animal was allowed to breathe spontaneously through a tracheostomy tube. Drug-induced changes in blood pressure and heart rate were monitored by means of a Statham P23 pressure transducer from a catheter inserted into the left carotid artery and recorded on a Grass model 7 polygraph. Drugs were administered via a catheter into the jugular vein.
Ganglion blocked anaesthetized rats
A state of ganglion blockade was induced in each rat by administering pentolinium (2.0 x 10-mol/kg).
The blockade was challenged with nicotine (6.2 x 107 mol/kg) 15 min after the administration of pentolinium and at intervals during the experiment. Further doses of pentolinium (8.4 x 10-6 mol/kg) were administered as required to maintain the blockade. A steady basal blood pressure was therefore established to facilitate measurement of pressor responses. Dose-response curves to Wy 20051 (2.4 x 10-6_3.0 x 10-4 mol/kg), noradrenaline (1.4 x 10-"1-1.5 x 10-8 mol/kg) or tyramine (1.8 x 10-8-4.7 x 10-6 mol/kg) were obtained, followed by constant submaximal doses of each agonist (9.4 x 10-6 mol/kg, 2.4 x 10-9 mol/kg and 2.9 x 10-7 mol/kg respectively). In some experiments, dose-response curves to noradrenaline were obtained before and after a dose of Wy 20051
(1.5 x 10-4 mol/kg cumulative). In other experiments a constant submaximal dose of Wy 20051 (1.9 x 10-i mol/kg) was administered every 7 min to anaesthetized rats and the effect on blood pressure recorded.
Reserpine-treated anaesthetized rats Reserpine (8.2 x 10-6 mol/kg i.p.) was administered to rats 24 h before the start of the experiments. Only those animals in which tyramine (1.8 x 10-8-4.7 x 10-6 mol/kg) did not evoke pressor responses were used. A dose-response curve to Wy 20051 (1.5 x 10-'-3.8 x 10-5 mol/kg) was then obtained in the reserpine-treated rats.
Isolated tissue studies
All isolated tissues were suspended in (or perfused with) Krebs solution of the following composition (mmol/itre): NaCl 118.4 (13.0), KCI 4.7 (110.0), NaHCO3 25.0, KH2PO4 1.2, CaCl2 2.5 (0.25), MgSO4 1.2, glucose 11.0. The figures in parentheses refer to a depolarizing solution used in certain experiments. When a calcium-free Krebs solution was used CaC12 was omitted and 5.0 x 10-4 mo/litre ethyleneglycol bis-(aminoethyl)-tetracetic acid was added as a calcium chelating agent.
Where necessary, ascorbic acid (1.0 x 10-4 moVlitre) was added to the bathing fluid to prevent oxidation of noradrenaline. Organ bath volume was 35 ml. Perfusion rate for the perfused mesenteric vasculature preparation was 2 ml/minute.
Responses were recorded by variable inductance transducers connected to a phase discriminator and pen recorder or, in the case of the mesenteric vasculature preparation, pressure changes were recorded via a Bell and Howell L221-2-3 pressure transducer on a Devices M2 pen recorder.
The tissues were left to equilibrate for 1 h before dosing was started.
Guinea-pig aortic spiral
Contractions of the guinea-pig aortic spiral (Furchgott & Bhadrakom, 1953) were recorded (load 0.5 g) in response to doses of noradrenaline (1.1 x 10-7 mol)
given at 5 min intervals until constant responses were obtained. The responses to Wy 20051 (3.8 x 10-5-1.2 x 10-3 mol cumulative) or noradrenaline (1.2 x 10-9-1.5 x 10-6 mol cumulative) were then observed.
Rat perfused mesenteric vasculature
The rat isolated perfused mesenteric vasculature preparation was set up as described by Collis & Alps (1973) vehicle. Agonists used in isolated tissue preparations were dissolved in either Krebs solution (aorta) or distilled water (mesentery).
Results

Ganglion-blocked anaesthetized rats
Effect on diastolic blood pressure and heart rate. Wy 20051 transiently increased diastolic pressure over the cumulative dose range 2.4 x 10-6-3.0 x 1j4 mo/kg. At higher doses (>3.8 x 10-5 mol/kg) these pressor responses were diminished (Figure 1) 
Reserpine-treated anaesthetized rats
The responses to tyramine previously obtained within the dose range 1.8 x 108-14.7 x 10-6 mol/kg were not evoked in rats pretreated with reserpine ( Figure 3a) . In contrast, responses to Wy 20051 were potentiated in reserpine-treated animals ( Figure 3b ).
Guinea-pig aortic spiral The Table 1 .
Depolarizing solution. A sustained contraction of the mesenteric vasculature was induced by the depolarizing solution described in the methods section (n = 4). Responses to doses of both noradrenaline and Wy 20051, which before depolarization had been equieffective, could be superimposed upon this contraction and were equally reduced in magnitude. In contrast no response was obtained to KCI ( Figure 6 ).
Effect of y-aminobutyric acid. The perfusion pressure of the isolated mesentery was unaltered by GABA (1.9 X 10-7-1.9 X 10-mol).
a-Adrenoceptor antagonism. High doses of Wy 20051 (4.7 x 10-5 mol) did not reduce the response of the mesenteric vasculature to subsequent doses of noradrenaline (4.7 x 10-9 mol) or KCI (1.1 x 10-5 mol). However, a single dose of phenoxybenzamine (3.3 x 10-10 mol) abolished the responses to noradrenaline leaving those to KCI unchanged.
Discussion
Wy 20051 elicited pressor responses in the intact anaesthetized ganglion blocked rat, constrictor responses in the isolated perfused mesenteric vasculature preparation of the rat and evoked contractions of the guinea-pig isolated aortic strip. The possibility that Wy 20051 was indirectly stimulating a-receptors by causing release of noradrenaline at sympathetic nerve endings was discounted since Wy 20051-induced pressor responses were potentiated in reserpine-treated rats compared with normal control animals. In contrast tyramine-induced responses were abolished except at high doses where the effect could be ascribed to a direct action on the vascular smooth muscle (Krzanowski & Woodbury, 1966) .
The reason for the potentiation of responses to Wy 20051 is not certain, but a non-specific supersensitivity to vasoactive agents other than catecholamines can result from reserpine treatment (Hudgins & Fleming, 1966) . It is well established that catecholamine depletion is accompanied by a specific tissue supersensitivity to catecholamines (Burn & Rand, 1958; Shore, 1962) which may be caused, in the case of reserpine, by reduced overall catecholamine uptake, leaving more free catecholamine to react with tissue receptors. Trendelenburg (1966) , whilst considering denervation supersensitivity in the nictitating membrane preparation, distinguished two components of supersensitivity, presynaptic and postsynaptic. Presynaptic supersensitivity is probably responsible for the specific effect on catecholamines whilst the non-specific supersensitivity for agents not taken up by adrenergic nerves such as peptides and, presumably, Wy 20051 may be due to vascular postsynaptic denervation supersensitivity. (Somlyo, Vinall & Somlyo, 1969.) Recent experiments show that reserpine increases the permeability of the muscle to calcium and acts, in addition, at some other calcium site to increase the availability of calcium for contraction (Carrier & Jurevics, 1973 (Nickerson, 1970 (Toda, 1973) . However, Ba2+ may also cause the release of Ca2+ (Bohr, 1964 (Figure 6 ). This phenomenon has been observed with maximal responses to different drugs in vascular smooth muscle (Somlyo & Somlyo, 1968a) . These characteristics of pharmacomechanical coupling have been extensively reviewed by Somlyo & Somlyo (1968b , 1970 and have been ascribed to a longer and more persistent increase in the permeability of the membrane to calcium than is produced by depolarization, rather than an ability of the drugs to translocate Ca2+ into the cytoplasm from a compartment not accessible to depolarization. They proposed that membrane bound Ca2+ regulates the permeability of the membrane to ionized calcium itself. Depolarization removes some membrane bound calcium which causes increased permeability. Drugs acting by a pharmacomechanical mechanism release membrane bound calcium or eliminate its stabilizing effect with or without removing it from bound sites.
The fact that noradrenaline produced consistently greater maximal responses than Wy 20051 both in vivo and in vitro suggests that noradrenaline was more able to overcome the stabilizing action of calcium and thereby produce a sustained increase in membrane permeability.
The tachyphylaxis of Wy 20051 pressor responses induced by high doses of the compound (3.8 x 10-5-3.0 x 10-4 mol/kg) in intact animals is interesting since noradrenaline responses are also significantly reduced when preceded by doses of this order (3.4 x 10-5 mol; Figure 2 ). However, no demonstrable a-adrenoceptor antagonism could be detected in the isolated perfused mesenteric vasculature with even larger bolus doses of Wy 20051 known to produce tachyphylaxis in this preparation (4.7 x 10-mol; Figure 5 ). In contrast, a single bolus dose of phenoxybenzamine (3.3 x 10-1 mol) abolished the mesenteric pressor response induced by noradrenaline (4.7 x 1t0-mol). These experiments suggest that the reduction of Wy 20051 and noradrenaline responses in vivo occurring when these agonists are preceded by supramaximal doses of Wy 20051 do not directly involve the a-adrenoceptor. Possible explanations for this tachyphylaxis include exhaustion of bound calcium by Wy 20051, or permanent damage of the cell membrane with consequent disruption of calcium fluxes.
The chemical resemblance of Wy 20051 to GABA does not seem to be important in the cardiovascular activity of this compound since GABA had no effect on the rat mesentery and reports suggest that GABA has a depressor effect on blood pressure which is dependent on an optimal distance between the amino acid and carboxyl groups (Takahaski, Tiba, lino & Takayasu, 1955) . The depressor action of GABA in the rabbit has been ascribed to an action on the medulla (Takahaski, Tiba, Yamazaki & Noguchi, 1958) and in dogs to peripheral ganglion blockade (Stanton & Woodhouse, 1959; Stanton, 1963) . However, pressor effects have been observed in the dog and may be due to carotid and aortic chemoreceptor stimulation.
In conclusion, Wy 20051 showed novel pharmacological activity in causing pressor responses in the intact animal and constrictor responses in the isolated perfused mesenteric vascular bed and guineapig isolated aorta. The contractions are calciumdependent and are due, at least in part, to an action on pharmacomechanical coupling in the vascular smooth muscle.
